222 related articles for article (PubMed ID: 6957882)
1. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882
[TBL] [Abstract][Full Text] [Related]
2. Glucocerebrosidase "processing" and gene expression in various forms of Gaucher disease.
Beutler E; Kuhl W; Sorge J
Am J Hum Genet; 1985 Nov; 37(6):1062-70. PubMed ID: 4083278
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
[TBL] [Abstract][Full Text] [Related]
4. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.
Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Grabowski GA; Dinur T; Osiecki KM; Kruse JR; Legler G; Gatt S
Am J Hum Genet; 1985 May; 37(3):499-510. PubMed ID: 4003396
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.
Jonsson LM; Murray GJ; Sorrell SH; Strijland A; Aerts JF; Ginns EI; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1987 Apr; 164(1):171-9. PubMed ID: 3549301
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts.
Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI
Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391
[TBL] [Abstract][Full Text] [Related]
8. Isozymes of beta-glucosidase: determination of Gaucher's disease phenotypes.
Ginns EI; Erickson A; Tegelaers FP; Barneveld R; Reuser AJ; Brady RO; Tager JM; Barranger JA
Isozymes Curr Top Biol Med Res; 1983; 11():83-93. PubMed ID: 6417048
[No Abstract] [Full Text] [Related]
9. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
Choy FY
Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
[TBL] [Abstract][Full Text] [Related]
10. Electrophoresis of glucocerebrosidase from normal and Gaucher disease fibroblasts.
Dale GL; Gudas J; Woloszyn W; Beutler E
Am J Hum Genet; 1979 Jul; 31(4):518-21. PubMed ID: 484554
[TBL] [Abstract][Full Text] [Related]
11. Determination of Gaucher's disease phenotypes with monoclonal antibody.
Ginns EI; Tegelaers FP; Barneveld R; Galjaard H; Reuser AJ; Brady RO; Tager JM; Barranger JA
Clin Chim Acta; 1983 Jul; 131(3):283-7. PubMed ID: 6883722
[TBL] [Abstract][Full Text] [Related]
12. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
[TBL] [Abstract][Full Text] [Related]
13. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO
Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138
[TBL] [Abstract][Full Text] [Related]
14. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
Grace ME; Graves PN; Smith FI; Grabowski GA
J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
[TBL] [Abstract][Full Text] [Related]
15. Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.
Michelakakis H; Dimitriou E; Van Weely S; Boot RG; Mavridou I; Verhoek M; Aerts JM
J Inherit Metab Dis; 1995; 18(5):609-15. PubMed ID: 8598642
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
18. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
[TBL] [Abstract][Full Text] [Related]
19. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM
Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530
[TBL] [Abstract][Full Text] [Related]
20. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
Choy FY
Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
